Healthcare Business

Boston Scientific

After Multiyear Turnaround, Is Boston Scientific Finally (and Really) Back?

Boston Scientific Corp. (NYSE: BSX) reported third-quarter results of $0.20 in earnings per share and $1.85 billion in revenue. That was against Thomson Reuters consensus estimates of $0.20 in earnings ...
Read Full Story »
Pills

3 Irish Specialty Pharmaceutical Stocks to Buy After Tax Inversion Implosion

For now, while the benefit for American corporations to buy or merge and move overseas may be over, as evidenced by AbbVie cancelling its merger with Shire Pharmaceutical, that doesn't ...
Read Full Story »
biotech

Biogen Takes Breather on Earnings and MS Drug Sales

Biogen Idec Inc. (NASDAQ: BIIB) reported its third-quarter results before the market opened Wednesday as $3.80 in earnings per share and $2.5 billion in revenue. That was against Thomson Reuters ...
Read Full Story »
Stock Split Image

The Plan to Drive Amgen Shares Up Over 70%

Amgen Inc. (NASDAQ: AMGN) used to be the king of biotech by size. That was then, and now is the time for a break-up or other efforts. At least that ...
Read Full Story »
biotech

Why Everyone Likes Illumina Again

Illumina Inc. (NASDAQ: ILMN) reported its earnings before the market opened Monday as $0.77 in earnings per share and $481 in revenue which beat out consensus estimates. On the heels ...
Read Full Story »
initial public offering

Connecture Files for IPO: Health Care Insurance Platform

Connecture Inc. has filed its S-1 form with the U.S. Securities and Exchange Commission (SEC) to have an initial public offering (IPO). No terms were given for the offering, but ...
Read Full Story »
health care

Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade

There had been some brief hopes that the worst was over for struggling MannKind Corp. (NASDAQ: MNKD). It turns out that not all great FDA approvals end up being great ...
Read Full Story »
Ebola Virus

Ebola Stock Fallout Severe on Monday

Is the Ebola scare over in the United States? Probably not by a long shot. That being said, Ebola fears are subsiding on Monday as dozens of people came off ...
Read Full Story »
Merger

NewLink Scores Major Partners With Roche’s Genentech

NewLink Genetics Corp. (NASDAQ: NLNK) announced that it has entered into an exclusive worldwide license agreement with Genentech, a member of the Roche Group, for the development of NLG919, NewLink's ...
Read Full Story »
research

Merrill Lynch’s 5 Destroyed Biotech Stocks With 100% or More Upside Potential

While Friday was a welcome relief for shell-shocked stock investors, much of the damage that has been inflicted since the start of the quarter is still weighing on some top ...
Read Full Story »
Ebola Virus

Ebola Stocks Move in Different Directions

Recently we have seen a surge in Ebola-related stocks across the board, but Friday trading brings a mixed view for this group. Allied Healthcare Products Inc. (NASDAQ: AHPI) in Friday ...
Read Full Story »
Ebola Virus

Ebola Stocks on the Move

Investors fan the flames of Ebola fears in the market, enabling these biotech companies to profit from these fears. Ultimately these fears and some hopes of potential contracts or increased ...
Read Full Story »
Biotechnology word cloud

Analyst Top Biotech Stocks Could Explode After Huge Sell-Off

When people are selling first and asking questions later, that is the exact time when savvy investors start to nibble at top stocks that have been hammered. As we reported ...
Read Full Story »
Johnson & Johnson Logo

Drug Sales Energize Johnson & Johnson Earnings

Johnson & Johnson (NYSE: JNJ) reported third-quarter 2014 results before markets opened Tuesday. The health care giant reported adjusted diluted earnings per share (EPS) of $1.50 on revenue of $18.47 ...
Read Full Story »
Ebola Virus

Ebola Fears Driving Ebola Stock Winners

Fears of Ebola have plagued the United States since late September, and some biotech companies have capitalized on this fear. These fears and some hopes of potential contracts or increased ...
Read Full Story »